Entares Pharmaceutical Private Limited
About Entares Pharmaceutical Private Limited
Data last updated:
Entares Pharmaceutical Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2019PTC049296. Its GSTIN is 23AAFCE5913N1ZI (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000. It is led by directors Madan Mohan Jha and Sushma Jha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 6 Grp No.13 Bhanpur Vidisha Road, Bhopal, Madhya Pradesh, India – 462038.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No – 6 Grp No.13 Bhanpur Vidisha Road, Bhopal, Madhya Pradesh, India – 462038
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Entares Pharmaceutical Private Limited
The main business activity of Entares Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Entares Pharmaceutical Private Limited FY 2025 filings available
Entares Pharmaceutical Private Limited reported revenue of ₹8,840 (down 49% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Entares Pharmaceutical Private Limited
Revenue fell 49% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Entares Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Entares Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Entares Pharmaceutical are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Entares Pharmaceutical Private Limited
Entares Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| NS Maja Expotrade Private Limited | ₹8,900 (FY 2022) | •••• | •••• | •••• | Patiala, Punjab, India | |
| Kalapriya Dealtrade Private Limited | ₹8,900 (FY 2017) | •••• | •••• | -36.0% | •••• | Kolkata, West Bengal, India |
| Narayani Trexim Private Limited | ₹8,900 (FY 2025) | •••• | •••• | 27.0% | •••• | Kolkata, West Bengal, India |
| Cromex Mercantile Private Limited | ₹8,850 (FY 2018) | •••• | •••• | -21.0% | •••• | Kolkata, West Bengal, India |
| Makdeal Sales Private Limited | ₹8,847 (FY 2022) | •••• | •••• | 475.0% | •••• | Pune, Maharashtra, India |
| Entares Pharmaceutical Private Limited this company | ₹8,840 (FY 2024) | •••• | •••• | -49.0% | •••• | Bhopal, Madhya Pradesh, India |
| Oindrila Specialities (OPC) Private Limited | ₹8,835 (FY 2019) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Aum Mediaid Private Limited | ₹8,834 (FY 2024) | •••• | •••• | -86.0% | •••• | New Delhi, Delhi, India |
| Rotterdam Agro Commodities Trading Limited | ₹8,830 (FY 2025) | •••• | •••• | -100.0% | •••• | Ahmedabad, Gujarat, India |
| Karm Yogi Pariwar Farmer Producer Company Limited | ₹8,816 (FY 2025) | •••• | •••• | -95.0% | •••• | Kushinagar, Uttar Pradesh, India |
| Avja Ventures Private Limited | ₹8,809 (FY 2025) | •••• | •••• | -100.0% | •••• | Agra, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Entares Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Entares Pharmaceutical Private Limited
Entares Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Mohan Jha | Director | 06 Aug 2019 | 7 Years 2 Months | Current |
| Sushma Jha Also directs: Novanice Pharmaceutical Private Limited | Director | 06 Aug 2019 | 7 Years 2 Months | Current |
Ownership and Shareholding of Entares Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Entares Pharmaceutical Private Limited
Entares Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Entares Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Entares Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Entares Pharmaceutical Private Limited
Entares Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Madan Mohan Jha was appointed as Director on 06 Aug 2019.
Credit Ratings, Litigation & Regulatory Alerts for Entares Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Entares Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Entares Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Entares Pharmaceutical Private Limited
Entares Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAFCE5913N1ZI | Madhya Pradesh | Active | 14 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Entares Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Entares Pharmaceutical Private Limited
Entares Pharmaceutical is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 August 2019 (7+ years old) and is registered under CIN U51909MP2019PTC049296.
Entares Pharmaceutical has 2 current directors:
- Madan Mohan Jha - Director
- Sushma Jha - Director
The GSTIN of Entares Pharmaceutical is 23AAFCE5913N1ZI, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Entares Pharmaceutical is U51909MP2019PTC049296. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Entares Pharmaceutical was incorporated on 06 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Entares Pharmaceutical by revenue are NS Maja Expotrade Private Limited, Kalapriya Dealtrade Private Limited, Narayani Trexim Private Limited, Cromex Mercantile Private Limited, Makdeal Sales Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Madan Mohan Jha was appointed as Director on 06 Aug 2019. Sushma Jha was appointed as Director on 06 Aug 2019.
The registered office of Entares Pharmaceutical is at Plot No – 6 Grp No.13 Bhanpur Vidisha Road, Bhopal, Madhya Pradesh, India – 462038.
Entares Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹50,000.
Entares Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Entares Pharmaceutical is not listed on any stock exchange. It is an unlisted company.